 |
인쇄하기
취소
|
Dong-A develops third drug
The Korea Food and Drug Administration has recently approved Dong-A Pharmaceutical’s anti-ulcerant drug Motilitone derived from natural substance.
Motilitone is Dong-A’s third homegrown medicine following Stillen and Zydena.
The company said that Motilitone was developed by a 6-year intensive study, adding clinical studies in 18 general hospitals indicated that the drug is effective in tr...
Motilitone is Dong-A’s third homegrown medicine following Stillen and Zydena.
The company said that Motilitone was developed by a 6-year intensive study, adding clinical studies in 18 general hospitals indicated that the drug is effective in tr...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.